Itraconazole and antiretroviral therapy: strategies for empirical dosing

Affiliations

¹ Division of Infectious Diseases, Departments of Medicine and Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E0J9, Canada; Global Health Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: ilan.steven.schwartz@gmail.com.
² Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Comment

Ilan S Schwartz et al. Lancet Infect Dis. 2017 Nov.

. 2017 Nov;17(11):1122-1123.

doi: 10.1016/S1473-3099(17)30568-6.

¹ Division of Infectious Diseases, Departments of Medicine and Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E0J9, Canada; Global Health Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: ilan.steven.schwartz@gmail.com.
² Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.

No abstract available

Comment in

Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply.
Le T, Adenis A, Limper A, Harrison T. Le T, et al. Lancet Infect Dis. 2017 Nov;17(11):1123-1124. doi: 10.1016/S1473-3099(17)30582-0. Lancet Infect Dis. 2017. PMID: 29115263 No abstract available.

Fungal infections in HIV/AIDS.
Limper AH, Adenis A, Le T, Harrison TS. Limper AH, et al. Lancet Infect Dis. 2017 Nov;17(11):e334-e343. doi: 10.1016/S1473-3099(17)30303-1. Epub 2017 Jul 31. Lancet Infect Dis. 2017. PMID: 28774701 Review.